Covaxin Junior: Bharat Biotech’s kids’ vaccine is good news. But why is its vaccine for adults yet to get WHO clearance? https://ift.tt/eA8V8J

Bharat Biotech is on the threshold of becoming the second Indian vaccine maker to receive an emergency use approval in the domestic market for a children’s Covid vaccine. The company’s vaccine, Covaxin, is already in use in the national programme. It’s supplied about 111 million doses, or 11.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/30px6lT